Seaport Therapeutics
Seaport Therapeutics is seeking a Clinical Trial Manager to lead the execution of clinical studies, ensuring they are completed on schedule, within budget, and in compliance with regulations. The role involves managing CROs and vendors, overseeing study timelines, budgets, and quality processes, and collaborating with cross‑functional teams and investigators.
Seaport Therapeutics is a biotechnology company developing novel neuropsychiatric medicines. The company applies its Glyph platform to advance potentially best-in-class therapeutics designed to improve efficacy and tolerability for patients with depression, anxiety, and other neuropsychiatric disorders.
Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Seaport’s GlyphCele™, the First Oral Therapeutic Designed to Restore Gut Lymphatic Function
2 weeks ago
Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan 5, 2026
Seaport Therapeutics Presents New Meta-Analysis Examining the Impact of Clinical Trial Design Factors on Placebo Response in Generalized Anxiety Disorder Trials
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Seaport Therapeutics.
Right around the average for this role
Clinical Trial Manager/Senior Clinical Trial Manager
Lexeo Therapeutics
Senior Clinical Trial Manager
Clinical Dynamix
Senior Clinical Trial Manager
Umoja Biopharma
Senior Clinical Trial Manager for Phase IV/Post-Marketing
Clinical Dynamix
Clinical Trial Manager/ Sr. Clinical Trial Manager
City Therapeutics
Clinical Trial Manager
Revolution Medicines